Taiwan FDA registration 25349183c3649a363ec355540e99ed91
"Guise" modular fully artificial hearing ossicle replacement
TW: “吉斯” 模組式全人工聽小骨置換物
Taiwan·Risk Class 2·GYRUS ENT LLC, A WHOLLY OWNED SUBSIDIARY OF GYRUS ACMI, INC.·Registered Jun 01, 2007 – Jun 01, 2017CancelledRegistration details
- Analysis ID
- 25349183c3649a363ec355540e99ed91
- Customs Code
- DHA00601810701
Company information
- Manufacturer Country
- United States
- Authorized Representative
- MEDFRONT MEDICAL TECHNOLOGY CORPORATION
Product details
- Intended Use
- For details, it is Chinese approved copy of the imitation order
- Product Type (Level 1)
- G ENT Science
- Product Type (Level 2)
- G.3495 Whole-hearing ossicle exchange
- Import Information
- import
Dates and status
- Registration Date
- Jun 01, 2007
- Expiry Date
- Jun 01, 2017
- Cancellation Date
- Nov 20, 2019
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for "Guise" modular fully artificial hearing ossicle replacement in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 25349183c3649a363ec355540e99ed91 and manufactured by GYRUS ENT LLC, A WHOLLY OWNED SUBSIDIARY OF GYRUS ACMI, INC.. The authorized representative in Taiwan is MEDFRONT MEDICAL TECHNOLOGY CORPORATION.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices